Literature DB >> 923045

The evolution of peripartal heart failure in Zaria, Nigeria. Some etiologic factors.

S J Fillmore, E H Parry.   

Abstract

The subsequent course of 173 women with severe congestive heart failure hospitalized within 6 months of delivery has been analyzed after 4 to 7 year follow-up periods. Forty-seven normotensive women and 50 women hypertensive only during the initial 48 hours have little long term morbidity. Thirty-six women with hypertension initially improved, but many are now showing enlarging cardiac silhouettes. Morbidity is increasing in this group. A similar, less severe pattern is developing in 36 women with intermittent hypertension. The uniquely high incidence of this condition in Zaria is associated with several locale factors. These Hausa-Fulani women eat large quantities of a local lake salt, kanwa, for 40 days postpartum. The syndrome is markedly more common in the hot rainy season, when evaporative water loss is less, than in the dry season. The first postpartum days are spent confined to bed in a small heated room. Once or twice daily the new mother is given hot baths with branches which have been dipped in boiling water. The combination of excessive sodium intake and diminished evaporative water excretion seems to precipitate failure in both normotensive and hypertensive patients.

Entities:  

Mesh:

Year:  1977        PMID: 923045     DOI: 10.1161/01.cir.56.6.1058

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

1.  Dilated cardiomyopathy: is it an entity specific to pregnancy?

Authors:  S Donnelly; S Blake; P McKenna; D Sugrue
Journal:  Ir J Med Sci       Date:  1992-11       Impact factor: 1.568

2.  Peripartum cardiomyopathy--successful treatment with cardiac transplantation.

Authors:  S G Joseph
Journal:  West J Med       Date:  1987-02

Review 3.  Heart failure in pregnancy.

Authors:  John D Rutherford
Journal:  Curr Heart Fail Rep       Date:  2012-12

Review 4.  Peripartum cardiomyopathy: a condition intensivists should be aware of.

Authors:  Esther de Beus; Walther N K A van Mook; Graham Ramsay; Jan L M Stappers; Hans W H M van der Putten
Journal:  Intensive Care Med       Date:  2003-01-17       Impact factor: 17.440

Review 5.  Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa.

Authors:  Bongani M Mayosi
Journal:  Heart       Date:  2007-10       Impact factor: 5.994

6.  Serum selenium and ceruloplasmin in nigerians with peripartum cardiomyopathy.

Authors:  Kamilu M Karaye; Isah A Yahaya; Krister Lindmark; Michael Y Henein
Journal:  Int J Mol Sci       Date:  2015-04-07       Impact factor: 5.923

7.  Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy.

Authors:  Britta Stapel; Michael Kohlhaas; Melanie Ricke-Hoch; Arash Haghikia; Sergej Erschow; Juhani Knuuti; Johanna M U Silvola; Anne Roivainen; Antti Saraste; Alexander G Nickel; Jasmin A Saar; Irina Sieve; Stefan Pietzsch; Mirco Müller; Ivan Bogeski; Reinhard Kappl; Matti Jauhiainen; James T Thackeray; Michaela Scherr; Frank M Bengel; Christian Hagl; Igor Tudorache; Johann Bauersachs; Christoph Maack; Denise Hilfiker-Kleiner
Journal:  Eur Heart J       Date:  2017-02-01       Impact factor: 29.983

8.  Incidence, clinical characteristics, and risk factors of peripartum cardiomyopathy in Nigeria: results from the PEACE Registry.

Authors:  K M Karaye; N A Ishaq; H Sa'idu; S A Balarabe; M A Talle; M S Isa; U G Adamu; H Umar; H I Okolie; M N Shehu; I Y Mohammed; B Sanni; O S Ogah; I Oboirien; E M Umuerri; A C Mankwe; V Y Shidali; P Njoku; S Dodiyi-Manuel; T T Shogade; T Olunuga; D Ojji; V Josephs; A C Mbakwem; J Tukur; S A Isezuo
Journal:  ESC Heart Fail       Date:  2020-01-28

9.  The 12-lead ECG in peripartum cardiomyopathy.

Authors:  Kemi Tibazarwa; Geraldine Lee; Bongani Mayosi; Melinda Carrington; Simon Stewart; Karen Sliwa
Journal:  Cardiovasc J Afr       Date:  2012-02-16       Impact factor: 1.167

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.